Covivio (COV) Earnings Call Transcripts

Covivio's Latest Earnings Call - Q2 FY2026

Covalon Technologies Ltd. reported a strong second quarter for fiscal 2026, with revenue of $8.7 million, representing a 15% increase year-over-year. The company also saw significant improvements in gross margins, reaching 61.5%, and adjusted EBITDA more than doubled to $1.3 million. Management expressed confidence in continued momentum, highlighting a strong balance sheet with no debt and a cash position of $16.6 million. Guidance for the second half of the fiscal year remains optimistic, with expectations for growth across all sales channels.

Reported metrics

Guidance from management

Management expects strong growth in the second half of fiscal 2026 across all sales channels, maintaining confidence in the business's direction and momentum.

What management said

Hi. Thanks, Angela, and good morning to all of you on the call today. We really appreciate you connecting in. Tim Crooks, our Chief Operating Officer; and Katie Martinovich, our Chief Financial Officer, have both joined me on the call here, and Saleha Assadzada from Covalon is helping to coordinate the conference call and the webcast today. Saleha will now provide us with some instructions.

Thank you, Brent. Good morning, everyone. My name is Saleha Assadzada, and I am the Executive Assistant, Covalon's Chief Executive Officer. I'd like to thank everyone for taking the time this morning to attend our conference call. Before we begin the discussion, I would like to remind participants that this call and webcast are covered by Covalon's safe harbor statement. Please read the safe harbor statement on this ...

What analysts pressed on

Analysts expressed concerns about the sustainability of the high gross margins and the potential impact of tariffs on future operations. There were also questions regarding the company's capital allocation strategy and whether they might pursue acquisitions or share buybacks.

Main topics on the call

• Strong Revenue Growth — Covalon achieved revenue of $8.7 million in Q2, a 15% increase from $7.6 million in the same quarter last year. Management emphasized that all sales channels experienced positive growth, particularly U.S. Vascular Access...
• Improved Gross Margins — Gross profit increased by almost 30% year-over-year to $5.4 million, with gross margin at 61.5%, up nearly 700 basis points from the previous year. Adjusted gross margin was even higher at approximately 63%, indicating e...
• Significant EBITDA Growth — Adjusted EBITDA rose to $1.3 million, a 127% increase compared to the same quarter last year. This growth reflects the company's focus on building scalable and profitable revenue streams.
• Category Creation in Contamination Prevention — Covalon is pioneering a new clinical category focused on contamination prevention in vascular access, anchored by its VALGuard and CovaClear products. Management noted significant traction with major hospitals adopting t...

Read the full Covivio transcript (Q2 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 54 Covivio earnings call transcripts on record, spanning January 29, 2020 to July 21, 2026. Based on this history, Covivio reports quarterly. The most recent call on file is dated July 21, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

COV

Exchange

ENXTPA

Country

FR

Sector

Real Estate

Industry

Diversified REITs

Calls on record

54

First call

January 29, 2020

Most recent

July 21, 2026

Reporting cadence

quarterly